Skip to main content

MSE News and Events

Michael Deagen (Ph.D., December 2018) received the Rensselaer Founders Award of Excellence at the Honors Convocation ceremony on October 20, 2018. Established in 1994, the Founders Award "honors students who embody qualities of creativity, discovery, leadership, and the values of pride and responsibility at Rensselaer."
This distinction is meant to honor young researchers who have made significant contributions to their respective fields within Polymer Science and Engineering.

Institute News

With the CHIPS and Science Act, the United States’ commitment to becoming a global leader in semiconductor manufacturing once again was formalized. After the recent global chips shortage, combined with the pervasiveness of chips in our everyday products from refrigerators, to cars, to watches, it is now a national priority to ensure that semiconductors are produced domestically for economic and security reasons.
Steve Eshiemogie, a doctoral student studying chemical and biological engineering at Rensselaer Polytechnic Institute, has been recognized as an honorable mention in the annual Cell Press Rising Black Scientists Awards for his essay “From village to lab: An African scientist’s quest for a sustainable future.” [MS1] More than 350 students across a range of scientific disciplines applied. 
From computer chips and pharmaceuticals to batteries and airplanes, our world runs on manufactured goods and products. However, most people rarely think about how these things get made — not to mention the technology and engineering that goes into making them at scale. 
Joan Llabre, Ph.D. '23, who received her doctorate in biomedical engineering from Rensselaer Polytechnic Institute this past fall and is now a postdoctoral researcher at the Institute, has won the Koerner Family Foundation Fellowship, which supports engineers pursuing careers in research. 
This year, Rensselaer Polytechnic Institute researchers will begin work on a radically new approach to treating and preventing genetic diseases such as Alzheimer’s.It’s thanks to a grant from the National Institutes of Health’s TARGETED Challenge, which funds scientific research on ways to deliver gene editing tools directly to cells in the human body.